Literature DB >> 847477

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain.

D R Burt, I Creese, S H Snyder.   

Abstract

Chronic treatment of rats with the neuroleptic drugs haloperidol, fluphenazine, and reserpine elicits a 20 to 25% increase in striatal dopamine receptor binding assayed with [3H]haloperidol. This increase in receptor sites may account for behavioral supersensitivity to dopamine receptor stimulants in such animals and for tardive dyskinesia in patients treated with these drugs.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 847477     DOI: 10.1126/science.847477

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  147 in total

Review 1.  Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia.

Authors:  C Konradi; S Heckers
Journal:  Biol Psychiatry       Date:  2001-11-15       Impact factor: 13.382

Review 2.  Oxidative mechanisms and tardive dyskinesia.

Authors:  James B Lohr; Ronald Kuczenski; Alexander B Niculescu
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

3.  Effects of ceruletide on the dopamine receptor-adenylate cyclase system in striatum and frontal cortex of rats chronically treated with haloperidol.

Authors:  Y Hatta; S Hatta; T Saito
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Differential effects of apomorphine in 6-hydroxydopamine-treated and aged rats.

Authors:  M D Schechter; J T Concannon
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brain.

Authors:  A Reches; V Jackson-Lewis; S Fahn
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.

Authors:  K J Pittman; A Jakubovic; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Modification of the behavioural effects of haloperidol and of dopamine receptor regulation by altered thyroid status.

Authors:  A D Crocker; D H Overstreet
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Treatment schedule as a determinant of the development of tolerance to haloperidol.

Authors:  R J Carey; J DeVeaugh-Geiss
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Neuroendocrine effects of clonidine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: relations to psychopathology.

Authors:  F Müller-Spahn; M Ackenheil; M Albus; C Botschev; D Naber; D Welter
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

10.  Comparative chronic effects of buspirone or neuroleptics on rat brain dopaminergic neurotransmission.

Authors:  B A McMillen
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.